Stephanie Mandos
Nurse Practitioner · Broomall, PANPI 1417472333
Payments from drug & device makers
Across 43 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$158
- UCB, Inc.$149
- Otsuka America Pharmaceutical, Inc.$108
- GSK$65
- AbbVie$56
- Sumitomo Pharma America, Inc.$49
- plus $371 from 13 others
What the payments were for
- Food & beverage$955100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 8 | $158 |
| UCB, Inc. | 6 | $149 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| GSK | 2 | $65 |
| AbbVie | 2 | $56 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Neurocrine Biosciences, Inc. | 2 | $47 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Novo Nordisk | 2 | $37 |
| Exact Sciences | 1 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $32 |
| Eisai Inc. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Biogen | 1 | $30 |
| Lundbeck LLC | 1 | $24 |
| Inari Medical, Inc. | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $14 |
| Pfizer | 1 | $13 |
How this compares
$955 in reported general payments places this provider in the 80th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $78,463 |
| OzempicSemaglutide | 38 | $47,610 |
| TrulicityDulaglutide | 45 | $45,470 |
| JardianceEmpagliflozin | 28 | $39,885 |
| XareltoRivaroxaban | 25 | $23,748 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $23,617 |
| MounjaroTirzepatide | 23 | $22,516 |
| JanuviaSitagliptin Phosphate | 16 | $19,397 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,787 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $8,762 |
| GemtesaVibegron | 15 | $7,970 |
| Potassium Chloride | 46 | $3,792 |
| Arnuity ElliptaFluticasone Furoate | 12 | $3,293 |
| Atorvastatin Calcium | 215 | $3,131 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,761 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $13 | $78,46383 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Olanzapine | $158 | $68,88281 claims |
| Novo NordiskOzempic | $37 | $47,61038 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $65 | $26,91049 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $49 | $7,97015 claims |
| AbbVieSynthroid | $56 | $1,12322 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $56453 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Broomall
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.